Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control.
about
Colloquium : 100 years of mass spectrometry: Perspectives and future trendsApplications of Fourier Transform Ion Cyclotron Resonance (FT-ICR) and Orbitrap Based High Resolution Mass Spectrometry in Metabolomics and LipidomicsTrends in the application of high-resolution mass spectrometry for human biomonitoring: An analytical primer to studying the environmental chemical space of the human exposomeScreening for illicit and medicinal drugs in whole blood using fully automated SPE and ultra-high-performance liquid chromatography with TOF-MS with data-independent acquisition.Mass spectrometry tools and workflows for revealing microbial chemistry.Targeted and non-targeted drug screening in whole blood by UHPLC-TOF-MS with data-independent acquisition.Optimization and Validation of High-Resolution Mass Spectrometry Data Analysis Parameters.Quantitative analysis of cortisol and 6β-hydroxycortisol in urine by fully automated SPE and ultra-performance LC coupled with electrospray and atmospheric pressure chemical ionization (ESCi)-TOF-MS.Simultaneous identification and quantification of new psychoactive substances in blood by GC-APCI-QTOFMS coupled to nitrogen chemiluminescence detection without authentic reference standards.Confounding factors and genetic polymorphism in the evaluation of individual steroid profilingThe development and validation of a method using high-resolution mass spectrometry (HRMS) for the qualitative detection of antiretroviral agents in human bloodA high-sensitivity ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urine.Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays.Systematic forensic toxicological analysis by GC-MS in serum using automated mass spectral deconvolution and identification system.Compound identification in forensic toxicological analysis with untargeted LC-MS-based techniques.Broad Screening and Identification of Novel Psychoactive Substances in Plasma by High-Performance Liquid Chromatography-High-Resolution Mass Spectrometry and Post-run Library Matching.Current applications of high-resolution mass spectrometry for the analysis of new psychoactive substances: a critical review.Applications of ambient mass spectrometry in high-throughput screening.Current status and bioanalytical challenges in the detection of unknown anabolic androgenic steroids in doping control analysis.Multi-target screening of biological samples using LC-MS/MS: focus on chromatographic innovations.Current position of high-resolution MS for drug quantification in clinical & forensic toxicology.Current status and recent advantages in derivatization procedures in human doping control.Multiple stage MS in analysis of plasma, serum, urine and in vitro samples relevant to clinical and forensic toxicology.Mass Spectrometry Applications for Toxicology.Simultaneous Screening and Quantification of Basic, Neutral and Acidic Drugs in Blood Using UPLC-QTOF-MS.Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine.Comparison of Different Time of Flight-Mass Spectrometry Modes for Small Molecule Quantitative Analysis.Patterns of drug abuse among drug users with regular and irregular attendance for treatment as detected by comprehensive UHPLC-HR-TOF-MS.Qualitative aspects and validation of a screening method for pesticides in vegetables and fruits based on liquid chromatography coupled to full scan high resolution (Orbitrap) mass spectrometry.Development and validation of an UHPLC-LTQ-Orbitrap MS method for non-anthocyanin flavonoids quantification in Euterpe oleracea juice.Do we need high-resolution MS in forensic and clinical toxicology?Identification of Novel Opioid Interferences using High-Resolution Mass Spectrometry.Evaluation of the interrelationship between mass resolving power and mass error tolerances for targeted bioanalysis using liquid chromatography coupled to high-resolution mass spectrometry.Strategy for non-target ionic analysis by capillary electrophoresis with ultraviolet detection.Drug use in pregnant women-a pilot study of the coherence between reported use of drugs and presence of drugs in plasma.Comparison of Post-targeted and Pre-targeted Urine Drug Screening by UHPLC-HR-QTOFMS.Identification and characterization of novel long-term metabolites of oxymesterone and mesterolone in human urine by application of selected reaction monitoring GC-CI-MS/MS.Monitoring few molecular binding events in scalable confined aqueous compartments by raster image correlation spectroscopy (CADRICS).Structural characterization of product ions by electrospray ionization and quadrupole time-of-flight mass spectrometry to support regulatory analysis of veterinary drug residues in foods.Liquid chromatography/time-of-flight mass spectrometry analysis of postmortem blood samples for targeted toxicological screening
P2860
Q21563835-37D11240-48B0-4AE1-8B74-DECDB8F39DCDQ26745581-4F25A197-6F04-45B5-AF26-DDFC66D1A59AQ29048606-91571533-8CEF-40CF-A049-09598844ECC7Q30619552-51FC66CF-5223-46B2-91C0-01ED57A66EC9Q30853422-BD5B680C-E24C-4970-A13F-98B1CE405698Q31137259-D88B9E96-70DC-4CA7-94A8-6D1C8C87A614Q31157429-CB3EF09F-BDEB-431C-BBEC-5CBCB7B466C8Q33456702-616462FE-BEEE-4E66-B51C-B301CE1047D3Q33467435-5F247FC5-6C5C-433D-BF46-8B1D20711ED6Q33659461-34493E50-59B7-445D-BD35-ED68F74A0255Q33690506-AF85C92A-8A6C-400D-8B3F-3648386EDE2BQ34364856-6528689F-D87F-495A-A540-7BF9AF662314Q34532586-9CE2C95A-4D75-4108-B009-A8413CEF0B96Q35762678-47C19650-286B-4E59-8D3C-31CBEFBD941CQ35840290-85832E73-447E-46EB-BA26-52CD99D73CC1Q36088120-258886E2-D5CB-4192-B0AF-153D8245ED08Q36410928-9357EFE7-0A91-4756-B8E3-E1BA0AEE75E3Q38095299-4732BE1D-C514-43BE-B25C-79FBB016E279Q38158183-36C62963-49F0-4008-BC47-7D484162F266Q38221657-58FE94A5-AB18-4AEA-A1FE-A6CE7D2B1201Q38266517-2031F644-DB8B-431F-8396-64C9443E04F6Q38607120-F5A490FC-DBF8-4DF8-9DA2-F9287338E248Q38754171-899D26AA-EDEC-4CF3-930D-7AC933E124D9Q39114251-70D8E8B3-629F-4A80-88FD-74AA90DE0236Q39157890-D88531D6-89A0-4CC9-AEBA-7CF1661D59FAQ39172040-2AF77DAC-EDEF-4E8E-842F-9D833B93FB68Q40663453-76EAD24D-D035-486A-B254-5B934232363AQ41199607-AFB41B8C-6AF3-4CB2-9EE8-6FCE1DFD685AQ42209740-01FDDC7A-B84D-471F-8597-D6AA9525AB7FQ43568512-34D8AF88-3C64-4CEA-8033-D824BCD58B50Q44258752-3DBABC90-EDD7-4EA5-9549-131C176582C8Q44349501-7BC20DDE-2AD8-4CAD-B039-D86A271D1984Q45908287-AD9DB7EC-E6F7-4259-96E6-B9AC3D917D2BQ46467512-B99080F0-F521-4FD0-872B-810B2D4A4BA9Q47271835-E267BCBF-C508-4B91-81AA-2EED9374E761Q48032412-BE0F839B-CD0E-412D-986A-836CDCCD40FAQ48122328-ACB8328A-DE66-4373-A274-23892F60089AQ51345366-56FD7129-995C-4459-98F5-659FDA5B79C3Q53721501-593D2389-0E3A-4133-B37B-BA0B32DDC087Q57212798-10160644-1342-4EDB-B264-37C755494116
P2860
Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Current use of high-resolution ...... toxicology and doping control.
@ast
Current use of high-resolution ...... toxicology and doping control.
@en
Current use of high-resolution ...... toxicology and doping control.
@nl
type
label
Current use of high-resolution ...... toxicology and doping control.
@ast
Current use of high-resolution ...... toxicology and doping control.
@en
Current use of high-resolution ...... toxicology and doping control.
@nl
prefLabel
Current use of high-resolution ...... toxicology and doping control.
@ast
Current use of high-resolution ...... toxicology and doping control.
@en
Current use of high-resolution ...... toxicology and doping control.
@nl
P2860
P1476
Current use of high-resolution ...... toxicology and doping control.
@en
P2093
Marjo Kolmonen
P2860
P2888
P304
P356
10.1007/S00216-012-5726-Z
P407
P577
2012-05-01T00:00:00Z